Pablo J. Cagnoni, Director at CRISPR Therapeutics AG (CRSP), sold 7,500 shares at $62.00 ($465K) on 2018-07-05, disclosed to the SEC on 2018-07-05.
Open-market sale of $465k CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.00 | 5,816 | $361K | 77.5% |
| 2 | $62.00 | 1,684 | $104K | 22.5% |
| Total | $62.00 avg | 7,500 | $465K | 100% |
| Filing → |
| INCY | SELL | 2026-08-14 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-07 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-04 | $1.9M | — | Filing → |